IN2013MU01222A - - Google Patents

Info

Publication number
IN2013MU01222A
IN2013MU01222A IN1222MU2013A IN2013MU01222A IN 2013MU01222 A IN2013MU01222 A IN 2013MU01222A IN 1222MU2013 A IN1222MU2013 A IN 1222MU2013A IN 2013MU01222 A IN2013MU01222 A IN 2013MU01222A
Authority
IN
India
Prior art keywords
sitagliptin
metformin
salts
present
compositions
Prior art date
Application number
Other languages
English (en)
Inventor
Girish Kumar Jain
Venkataramana Naidu
Atul Patil
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to US14/766,939 priority Critical patent/US20150366863A1/en
Priority to IN1222MU2013 priority patent/IN2013MU01222A/en
Priority to PCT/IB2014/060081 priority patent/WO2014170770A1/en
Priority to EP14722341.6A priority patent/EP2996680A1/en
Publication of IN2013MU01222A publication Critical patent/IN2013MU01222A/en
Priority to ZA2015/05916A priority patent/ZA201505916B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1222MU2013 2013-03-28 2014-03-24 IN2013MU01222A (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US14/766,939 US20150366863A1 (en) 2013-03-28 2014-03-24 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof
IN1222MU2013 IN2013MU01222A (es) 2013-03-28 2014-03-24
PCT/IB2014/060081 WO2014170770A1 (en) 2013-03-28 2014-03-24 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof
EP14722341.6A EP2996680A1 (en) 2013-03-28 2014-03-24 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof
ZA2015/05916A ZA201505916B (en) 2013-03-28 2015-08-17 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1222MU2013 IN2013MU01222A (es) 2013-03-28 2014-03-24

Publications (1)

Publication Number Publication Date
IN2013MU01222A true IN2013MU01222A (es) 2015-04-17

Family

ID=54395589

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1222MU2013 IN2013MU01222A (es) 2013-03-28 2014-03-24

Country Status (1)

Country Link
IN (1) IN2013MU01222A (es)

Similar Documents

Publication Publication Date Title
PH12021550792A1 (en) 2-(morpholin-4-yl)-1,7-naphthyridines
PH12016501581A1 (en) Benzimidazol-2-amines as midh1 inhibitors
PH12015502615B1 (en) Chemical compounds
PH12016501807A1 (en) Novel compounds
EA201791363A1 (ru) Пиразолопиридинамины в качестве ингибиторов mknk1 и mknk2
PH12016500054A1 (en) Substituted pyrazolo-pyridinamines
PH12016501932A1 (en) Amido-substituted azole compounds
PH12016501814A1 (en) Inhibitors of the wnt signalling pathways
BR112017004580A2 (pt) composto, composição farmacêutica, produto de combinação, uso de um composto ou sal farmaceuticamente aceitável, e, método de tratamento.
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
EA033769B9 (ru) Отселектированный амид -гидроксимасляной кислоты и его применения при лечении злоупотребления алкоголем
IN2013MU03847A (es)
GEP201706614B (en) Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
MX2016014261A (es) Uso de acido 1,3-propandisulfonico o sales farmaceuticamente aceptables del mismo para el tratamiento de sarcoidosis.
IN2013MU01222A (es)
IN2013MU03428A (es)
IN2013MU01224A (es)
GEP20207145B (en) Combination of trazodone and gabapentin for the treatmen
IN2013MU01223A (es)
IN2013MU01225A (es)
PH12015501179A1 (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine
MX2016003763A (es) Terapia de combinacion con laquinimod para tratamiento de esclerosis multiple.
MA39762A (fr) Nouveaux composés
IN2013MU01159A (es)
IN2013MU01158A (es)